Answers are grounded in this paper and cite their sources.
Case report demonstrates successful treatment using an add-on contezolid regimen in severe tuberculosis complicated by acute thrombocytopenia, suggesting a safe alternative to standard therapy.
Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against Mycobacterium tuberculosis. Contezolid add‐on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: